Adverse effects of 2-Methoxyestradiol on mouse oocytes during reproductive aging

2-Methoxyestradiol (2-ME2) is a metabolite of 17 beta-estradiol and is currently in clinical trials as an antitumor agent. Here we found 2-ME2 level remains stable in the local environment of ovaries but declines in serum in aging mice, and exogenous 2-ME2 impacts the meiotic maturation of mouse oocytes in dose-dependent manner. In vitro 2-ME2 application arrested oocytes at metaphase I (MI), with abnormal spindle structure and chromo-some alignment. 2-ME2 exposure induced excessive production of reactive oxygen species (ROS) and malon-dialdehyde, as well as accelerated apoptosis progression. 2-ME2 unbalanced mitochondrial dynamics by increasing DRP1 and MFN1 while decreasing Opa1. Similar phenotypes were also observed in oocytes from mice injected intraperitoneally with 2-ME2. Taken together, this study indicates 2-ME2 exposure impairs oocyte meiotic maturation through inducing mitochondrial imbalance, oxidative stress and apoptosis. The gradual decline in oocyte quality and quantity may be associated with the stable 2-ME2 in ovaries during female reproductive aging.

Automated summary

2-Methoxyestradiol (2-ME2), a metabolite of 17 beta-estradiol, is being studied as an antitumor agent. This study found that while 2-ME2 levels remain stable in the ovaries of aging mice, it declines in the serum. Exposure to 2-ME2 affects the meiotic maturation of mouse oocytes, leading to abnormal spindle structure and chromosome alignment. The study suggests that the impairment of oocyte maturation caused by 2-ME2 exposure is due to mitochondrial imbalance, oxidative stress, and apoptosis.